These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30336979)

  • 1. Role of Dicer in regulating oxaliplatin resistance of colon cancer cells.
    Lai HH; Lin LJ; Hung LY; Chen PS
    Biochem Biophys Res Commun; 2018 Nov; 506(1):87-93. PubMed ID: 30336979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis.
    Wang H; Li H; Zhang L; Yang D
    Biomed Pharmacother; 2018 Oct; 106():1607-1615. PubMed ID: 30119236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA CACS15 contributes to oxaliplatin resistance in colorectal cancer by positively regulating ABCC1 through sponging miR-145.
    Gao R; Fang C; Xu J; Tan H; Li P; Ma L
    Arch Biochem Biophys; 2019 Mar; 663():183-191. PubMed ID: 30639170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagic degradation of SQSTM1 inhibits ovarian cancer motility by decreasing DICER1 and AGO2 to induce MIRLET7A-3P.
    Liao CC; Ho MY; Liang SM; Liang CM
    Autophagy; 2018; 14(12):2065-2082. PubMed ID: 30081720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM25 regulates oxaliplatin resistance in colorectal cancer by promoting EZH2 stability.
    Zhou S; Peng J; Xiao L; Zhou C; Fang Y; Ou Q; Qin J; Liu M; Pan Z; Hou Z
    Cell Death Dis; 2021 May; 12(5):463. PubMed ID: 33966039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIF-1α promotes autophagic proteolysis of Dicer and enhances tumor metastasis.
    Lai HH; Li JN; Wang MY; Huang HY; Croce CM; Sun HL; Lyu YJ; Kang JW; Chiu CF; Hung MC; Suzuki HI; Chen PS
    J Clin Invest; 2018 Feb; 128(2):625-643. PubMed ID: 29251629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma.
    Vaksman O; Hetland TE; Trope' CG; Reich R; Davidson B
    Hum Pathol; 2012 Nov; 43(11):2062-9. PubMed ID: 22647351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirements for human Dicer and TRBP in microRNA-122 regulation of HCV translation and RNA abundance.
    Zhang C; Huys A; Thibault PA; Wilson JA
    Virology; 2012 Nov; 433(2):479-88. PubMed ID: 22999255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of Dicer and Ago2 is associated with cell proliferation and apoptosis in prostate cancer.
    Bian XJ; Zhang GM; Gu CY; Cai Y; Wang CF; Shen YJ; Zhu Y; Zhang HL; Dai B; Ye DW
    Tumour Biol; 2014 Nov; 35(11):11571-8. PubMed ID: 25135428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
    Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
    World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
    Huang C; Wang M; Wang J; Wu D; Gao Y; Huang K; Yao X
    Biochem Pharmacol; 2021 Jul; 189():114390. PubMed ID: 33359068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dicer regulates non-homologous end joining and is associated with chemosensitivity in colon cancer patients.
    Chen X; Li WF; Wu X; Zhang HC; Chen L; Zhang PY; Liu LY; Ma D; Chen T; Zhou L; Xu Y; Zhou MT; Tang KF
    Carcinogenesis; 2017 Sep; 38(9):873-882. PubMed ID: 28911000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of Drosha, DGCR8, Dicer and Ago-2 genes are upregulated in human umbilical vein endothelial cells under hyperglycemic condition.
    Soufi FG; Zonouzi AAP; Eftekhar E; Kamali K; Chegeni SA; Zonouzi AP
    Endocr Regul; 2018 Jul; 52(3):123-127. PubMed ID: 31517606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis.
    Hsu HH; Chen MC; Baskaran R; Lin YM; Day CH; Lin YJ; Tu CC; Vijaya Padma V; Kuo WW; Huang CY
    J Cell Physiol; 2018 Jul; 233(7):5458-5467. PubMed ID: 29247488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin F
    Wang YJ; Xie XL; Liu HQ; Tian H; Jiang XY; Zhang JN; Chen SX; Liu T; Wang SL; Zhou X; Jin XX; Liu SM; Jiang HQ
    World J Gastroenterol; 2023 Oct; 29(39):5452-5470. PubMed ID: 37900995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dicer affects cisplatin‑mediated apoptosis in epithelial ovarian cancer cells.
    Wang X; Chen H; Wen Y; Yang X; Han Q; Jiang P; Huang Z; Cai J; Wang Z
    Mol Med Rep; 2018 Nov; 18(5):4381-4387. PubMed ID: 30221734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas.
    Prodromaki E; Korpetinou A; Giannopoulou E; Vlotinou E; Chatziathanasiadou Μ; Papachristou NI; Scopa CD; Papadaki H; Kalofonos HP; Papachristou DJ
    Cell Oncol (Dordr); 2015 Aug; 38(4):307-17. PubMed ID: 26227789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the shRNA characteristics that hinder Dicer recognition and consequently allow Ago-mediated processing and AgoshRNA activity.
    Herrera-Carrillo E; Harwig A; Liu YP; Berkhout B
    RNA; 2014 Sep; 20(9):1410-8. PubMed ID: 25035295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells.
    Plasencia C; Martínez-Balibrea E; Martinez-Cardús A; Quinn DI; Abad A; Neamati N
    Int J Oncol; 2006 Jul; 29(1):225-35. PubMed ID: 16773204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydrogenase/reductase SDR family member 2 silencing sensitizes an oxaliplatin‑resistant cell line to oxaliplatin by inhibiting excision repair cross‑complementing group 1 protein expression.
    Li JM; Jiang GM; Zhao L; Yang F; Yuan WQ; Wang H; Luo YQ
    Oncol Rep; 2019 Nov; 42(5):1725-1734. PubMed ID: 31436301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.